NCT02503423 2026-03-20Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and LymphomasTaiho Oncology, Inc.Phase 1/2 Active not recruiting253 enrolled
NCT05403450 2026-02-23A Study of Tolinapant in Combination With Oral Decitabine/Cedazuridine and Oral Decitabine/Cedazuridine Alone in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma (R/R PTCL)Taiho Oncology, Inc.Phase 1 Active not recruiting33 enrolled